ADVANCED ENZYME TECHNOLOGIES
Back to Cashflow Statement
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹142 Cr | ₹141 Cr | ₹140 Cr | ₹122 Cr | ₹163 Cr |
What is the latest Cash Flow from Operating Activities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹142 Cr |
| Mar2024 | ₹141 Cr |
| Mar2023 | ₹140 Cr |
| Mar2022 | ₹122 Cr |
| Mar2021 | ₹163 Cr |
How is Cash Flow from Operating Activities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹142 Cr | 0.80 | |
| Mar2024 | ₹141 Cr | 0.72 | |
| Mar2023 | ₹140 Cr | 14.78 | |
| Mar2022 | ₹122 Cr | -24.96 | |
| Mar2021 | ₹163 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,261.9 Cr | -1.7% | -3.9% | -13% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,847.0 Cr | 6.8% | -1.5% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,745.0 Cr | 0% | -4.8% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,346.0 Cr | 1.7% | 4.1% | 20.5% | Stock Analytics | |
| CIPLA | ₹107,075.0 Cr | 0.1% | -12.8% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,507.0 Cr | 1.8% | -0.7% | 3.4% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -1.7% |
-3.9% |
-13% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses